These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16178727

  • 1. Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors.
    Bolós J.
    Mini Rev Med Chem; 2005 Sep; 5(9):857-68. PubMed ID: 16178727
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. p38 MAP kinase inhibitors as anti inflammatory agents.
    Amir M, Somakala K, Ali S.
    Mini Rev Med Chem; 2013 Dec; 13(14):2082-96. PubMed ID: 24107108
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies.
    Gangwal RP, Bhadauriya A, Damre MV, Dhoke GV, Sangamwar AT.
    Curr Top Med Chem; 2013 Dec; 13(9):1015-35. PubMed ID: 23651481
    [Abstract] [Full Text] [Related]

  • 6. Tri- and tetrasubstituted imidazoles as p38α mitogen-activated protein kinase inhibitors.
    Laufer S, Hauser D, Stegmiller T, Bracht C, Ruff K, Schattel V, Albrecht W, Koch P.
    Bioorg Med Chem Lett; 2010 Nov 15; 20(22):6671-5. PubMed ID: 20934337
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors.
    Das J, Moquin RV, Pitt S, Zhang R, Shen DR, McIntyre KW, Gillooly K, Doweyko AM, Sack JS, Zhang H, Kiefer SE, Kish K, McKinnon M, Barrish JC, Dodd JH, Schieven GL, Leftheris K.
    Bioorg Med Chem Lett; 2008 Apr 15; 18(8):2652-7. PubMed ID: 18359226
    [Abstract] [Full Text] [Related]

  • 9. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
    Fox T, Coll JT, Xie X, Ford PJ, Germann UA, Porter MD, Pazhanisamy S, Fleming MA, Galullo V, Su MS, Wilson KP.
    Protein Sci; 1998 Nov 15; 7(11):2249-55. PubMed ID: 9827991
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and biological evaluation of novel Tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: focus on optimized interactions with the enzyme's surface-exposed front region.
    Laufer SA, Hauser DR, Domeyer DM, Kinkel K, Liedtke AJ.
    J Med Chem; 2008 Jul 24; 51(14):4122-49. PubMed ID: 18578517
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amide-based inhibitors of p38alpha MAP kinase. Part 1: discovery of novel N-pyridyl amide lead molecules.
    Luedtke GR, Schinzel K, Tan X, Tester RW, Nashashibi I, Xu YJ, Dugar S, Levy DE, Jung J.
    Bioorg Med Chem Lett; 2010 Apr 15; 20(8):2556-9. PubMed ID: 20346653
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
    Kim DK, Lim JH, Lee JA, Dewang PM.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):4006-10. PubMed ID: 18571921
    [Abstract] [Full Text] [Related]

  • 20. Small molecular anti-cytokine agents.
    Wagner G, Laufer S.
    Med Res Rev; 2006 Jan 15; 26(1):1-62. PubMed ID: 16283677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.